J&J-Guidant Merger Spotlights Stent Patent Wars
By Marius Meland · November 15, 2005, 12:00 AM EST
Johnson & Johnson's pending $21.5 billion acquisition of Guidant, one of the largest mergers in the history of the medical device industry, puts the spotlight on the intense legal battle over...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login